Abstract
KIT D816V mutation within exon 17 has been particularly reported as one of the poor prognostic factors in pediatric acute myeloid leukemia (AML) with RUNX1-RUNX1T1. The exact frequency and the prognostic impact of KIT D816V minor clones at diagnosis were not examined. In this study, the minor clones were examined and the prognostic significance of KIT D816V mutation in pediatric patients was investigated. Consequently, 24 KIT D816V mutations (7.2%) in 335 pediatric patients were identified, and 12 of 24 were only detected via the digital droplet polymerase chain reaction method. All 12 patients were confined in core binding factor (CBF)-AML patients. The 5 year event-free survival of the patients with KIT D816V mutation was significantly inferior to those without KIT D816V mutation (44.1% [95% confidence interval (CI), 16.0%-69.4%] vs. 74.7% [95% CI, 63.0%-83.2%] P-value = 0.02, respectively). The 5 year overall survival was not different between the two groups (92.9% [95% CI, 59.0%-NA vs. 89.7% [95% CI, 69.6%-96.8%] P-value = 0.607, respectively). In this study, KIT D816V minor clones in patients with CBF-AML were confirmed and KIT D816V was considered as a risk factor for relapse in patients with RUNX1-RUNX1T1-positive AML.
References
Nov 18, 2005·Blood·Akira ShimadaYasuhide Hayashi
Dec 31, 2005·Blood·Roberto CairoliEnrica Morra
Jul 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ichiro TsukimotoRyoji Hanada
Nov 13, 2009·Genes, Chromosomes & Cancer·Dan JonesHagop Kantarjian
May 11, 2010·The Lancet Oncology·Jeffrey E RubnitzDario Campana
Sep 29, 2011·Blood·Ursula CreutzigDirk Reinhardt
Nov 2, 2012·Blood·Peter PaschkaKonstanze Döhner
Dec 5, 2012·Bone Marrow Transplantation·Y Kanda
Jan 17, 2013·Blood·Eric JourdanUNKNOWN French AML Intergroup
May 17, 2013·Leukemia·D TomizawaS Adachi
May 16, 2015·Leukemia·M TokumasuS Adachi
Nov 18, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kim KleinBrenda Gibson
Oct 28, 2016·British Journal of Haematology·Norio ShibaYasuhide Hayashi
Nov 1, 2016·Nature Genetics·Zachary J FaberJames R Downing
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ilaria Iacobucci, Charles G Mullighan
May 4, 2018·Leukemia·Peter PaschkaHartmut Döhner
Sep 27, 2018·Annals of Hematology·Naomi KawashimaUNKNOWN Japan Adult Leukemia Study Group (JALSG)
Dec 21, 2018·Leukemia·Nicola PotterMel Greaves
Jun 12, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Katherine TarlockJessica A Pollard
Jun 28, 2019·British Journal of Haematology·Kenichi SakamotoToshihiko Imamura
Jul 17, 2019·Pediatric Blood & Cancer·Nobuyuki HyakunaKoji Kato
Jan 4, 2020·Blood Advances·Yuichi IshikawaHitoshi Kiyoi
Jul 8, 2020·Cancers·Susanna GrassiSara Galimberti
Sep 25, 2020·ESMO Open·Noelia TarazonaAndrés Cervantes